GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery
Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein) (Spastic paraplegia 21 protein)
SPG21_HUMAN Reviewed; 308 AA.
Q9NZD8; B4DW44; Q6ZMB6;
21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
01-OCT-2000, sequence version 1.
25-APR-2018, entry version 140.
RecName: Full=Maspardin;
AltName: Full=Acid cluster protein 33;
AltName: Full=Spastic paraplegia 21 autosomal recessive Mast syndrome protein;
AltName: Full=Spastic paraplegia 21 protein;
Name=SPG21; Synonyms=ACP33; ORFNames=BM-019, GL010;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
SUBCELLULAR LOCATION, INTERACTION WITH CD4, AND MUTAGENESIS OF
SER-109.
PubMed=11113139; DOI=10.1074/jbc.M009270200;
Zeitlmann L., Sirim P., Kremmer E., Kolanus W.;
"Cloning of ACP33 as a novel intracellular ligand of CD4.";
J. Biol. Chem. 276:9123-9132(2001).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Bone marrow;
Zhao M., Song H., Li N., Peng Y., Han Z., Chen Z.;
"A novel gene expressed in human bone marrow.";
Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Liver;
Li Y., Wu T., Xu S., Ren S., Chen Z., Han Z.;
"A novel gene expressed in human liver non-tumor tissues.";
Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Synovium;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16572171; DOI=10.1038/nature04601;
Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
Nusbaum C.;
"Analysis of the DNA sequence and duplication history of human
chromosome 15.";
Nature 440:671-675(2006).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Eye;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
INVOLVEMENT IN SPG21.
PubMed=14564668; DOI=10.1086/379522;
Simpson M.A., Cross H., Proukakis C., Pryde A., Hershberger R.,
Chatonnet A., Patton M.A., Crosby A.H.;
"Maspardin is mutated in Mast syndrome, a complicated form of
hereditary spastic paraplegia associated with dementia.";
Am. J. Hum. Genet. 73:1147-1156(2003).
[9]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19413330; DOI=10.1021/ac9004309;
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
Mohammed S.;
"Lys-N and trypsin cover complementary parts of the phosphoproteome in
a refined SCX-based approach.";
Anal. Chem. 81:4493-4501(2009).
[10]
INTERACTION WITH ALDH16A1.
PubMed=19184135; DOI=10.1007/s10048-009-0172-6;
Hanna M.C., Blackstone C.;
"Interaction of the SPG21 protein ACP33/maspardin with the aldehyde
dehydrogenase ALDH16A1.";
Neurogenetics 10:217-228(2009).
[11]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=20068231; DOI=10.1126/scisignal.2000475;
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
Mann M.;
"Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis.";
Sci. Signal. 3:RA3-RA3(2010).
[12]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
-!- FUNCTION: May play a role as a negative regulatory factor in CD4-
dependent T-cell activation. {ECO:0000269|PubMed:11113139}.
-!- SUBUNIT: Interacts with CD4. Interacts with ALDH16A1.
{ECO:0000269|PubMed:11113139, ECO:0000269|PubMed:19184135}.
-!- INTERACTION:
Q6RW13:AGTRAP; NbExp=4; IntAct=EBI-742688, EBI-741181;
Q53H80:AKIRIN2; NbExp=5; IntAct=EBI-742688, EBI-742928;
Q15041:ARL6IP1; NbExp=5; IntAct=EBI-742688, EBI-714543;
Q8N5M1:ATPAF2; NbExp=13; IntAct=EBI-742688, EBI-1166928;
Q68D86:CCDC102B; NbExp=3; IntAct=EBI-742688, EBI-10171570;
P42772:CDKN2B; NbExp=4; IntAct=EBI-742688, EBI-711280;
Q9Y6K0:CEPT1; NbExp=4; IntAct=EBI-742688, EBI-1237183;
Q96DZ9:CMTM5; NbExp=3; IntAct=EBI-742688, EBI-2548702;
Q96JB2-2:COG3; NbExp=4; IntAct=EBI-742688, EBI-9091495;
P02489:CRYAA; NbExp=5; IntAct=EBI-742688, EBI-6875961;
Q9NRF8:CTPS2; NbExp=4; IntAct=EBI-742688, EBI-740874;
Q9NTM9:CUTC; NbExp=5; IntAct=EBI-742688, EBI-714918;
Q86UW9:DTX2; NbExp=6; IntAct=EBI-742688, EBI-740376;
Q8TDB6:DTX3L; NbExp=5; IntAct=EBI-742688, EBI-2340392;
Q5JST6:EFHC2; NbExp=5; IntAct=EBI-742688, EBI-2349927;
Q8IWE2:FAM114A1; NbExp=5; IntAct=EBI-742688, EBI-2686288;
Q9UJY4:GGA2; NbExp=3; IntAct=EBI-742688, EBI-447646;
Q08379:GOLGA2; NbExp=4; IntAct=EBI-742688, EBI-618309;
Q9UKT9:IKZF3; NbExp=5; IntAct=EBI-742688, EBI-747204;
Q0VD86:INCA1; NbExp=5; IntAct=EBI-742688, EBI-6509505;
P19012:KRT15; NbExp=3; IntAct=EBI-742688, EBI-739566;
Q9UJV3-2:MID2; NbExp=5; IntAct=EBI-742688, EBI-10172526;
Q15742:NAB2; NbExp=4; IntAct=EBI-742688, EBI-8641936;
P60891:PRPS1; NbExp=6; IntAct=EBI-742688, EBI-749195;
Q9UI14:RABAC1; NbExp=6; IntAct=EBI-742688, EBI-712367;
Q96HR9:REEP6; NbExp=3; IntAct=EBI-742688, EBI-750345;
P04271:S100B; NbExp=5; IntAct=EBI-742688, EBI-458391;
Q7Z698:SPRED2; NbExp=7; IntAct=EBI-742688, EBI-7082156;
P03410:tax (xeno); NbExp=3; IntAct=EBI-742688, EBI-9676218;
Q99081:TCF12; NbExp=3; IntAct=EBI-742688, EBI-722877;
P15884:TCF4; NbExp=3; IntAct=EBI-742688, EBI-533224;
Q8WW24:TEKT4; NbExp=4; IntAct=EBI-742688, EBI-750487;
Q92734:TFG; NbExp=5; IntAct=EBI-742688, EBI-357061;
Q13077:TRAF1; NbExp=5; IntAct=EBI-742688, EBI-359224;
Q12933:TRAF2; NbExp=6; IntAct=EBI-742688, EBI-355744;
P36406:TRIM23; NbExp=3; IntAct=EBI-742688, EBI-740098;
Q9BYV2:TRIM54; NbExp=5; IntAct=EBI-742688, EBI-2130429;
Q9C026:TRIM9; NbExp=5; IntAct=EBI-742688, EBI-720828;
Q2TAA8:TSNAXIP1; NbExp=4; IntAct=EBI-742688, EBI-6872498;
Q6PF05:TTC23L; NbExp=4; IntAct=EBI-742688, EBI-8656864;
P10599:TXN; NbExp=4; IntAct=EBI-742688, EBI-594644;
-!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
{ECO:0000269|PubMed:11113139}. Membrane
{ECO:0000269|PubMed:11113139}; Peripheral membrane protein
{ECO:0000269|PubMed:11113139}. Endosome membrane
{ECO:0000269|PubMed:11113139}; Peripheral membrane protein
{ECO:0000269|PubMed:11113139}. Golgi apparatus, trans-Golgi
network membrane {ECO:0000269|PubMed:11113139}; Peripheral
membrane protein {ECO:0000269|PubMed:11113139}. Note=Partially
localized in the cytosol but also accumulated on an intracellular
vesicular compartment. Colocalizes with CD4 on endosomal/trans-
Golgi network.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q9NZD8-1; Sequence=Displayed;
Name=2;
IsoId=Q9NZD8-2; Sequence=VSP_041512;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Expressed in all tissues tested, including
heart, brain, placenta, lung, liver, skeletal muscle, kidney and
pancreas. Expressed in J.CaM1.6, HuT 78 and HeLa cell lines (at
protein level). {ECO:0000269|PubMed:11113139}.
-!- DISEASE: Spastic paraplegia 21, autosomal recessive (SPG21)
[MIM:248900]: A form of spastic paraplegia, a neurodegenerative
disorder characterized by a slow, gradual, progressive weakness
and spasticity of the lower limbs. Rate of progression and the
severity of symptoms are quite variable. Initial symptoms may
include difficulty with balance, weakness and stiffness in the
legs, muscle spasms, and dragging the toes when walking. In some
forms of the disorder, bladder symptoms (such as incontinence) may
appear, or the weakness and stiffness may spread to other parts of
the body. SPG21 is associated with dementia and other central
nervous system abnormalities. Subtle childhood abnormalities may
be present, but the main features develop in early adulthood. The
disease is slowly progressive, and cerebellar and extrapyramidal
signs are also found in patients with advanced disease. Patients
have a thin corpus callosum and white-matter abnormalities.
{ECO:0000269|PubMed:14564668}. Note=The disease is caused by
mutations affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the AB hydrolase superfamily.
{ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF208861; AAF64275.1; -; mRNA.
EMBL; AF212231; AAK14917.1; -; mRNA.
EMBL; AK172849; BAD18813.1; -; mRNA.
EMBL; AK301362; BAG62906.1; -; mRNA.
EMBL; AC069368; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AC103691; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471082; EAW77704.1; -; Genomic_DNA.
EMBL; BC000244; AAH00244.1; -; mRNA.
CCDS; CCDS10198.1; -. [Q9NZD8-1]
CCDS; CCDS45279.1; -. [Q9NZD8-2]
RefSeq; NP_001121361.1; NM_001127889.4. [Q9NZD8-1]
RefSeq; NP_001121362.1; NM_001127890.4. [Q9NZD8-2]
RefSeq; NP_057714.1; NM_016630.6. [Q9NZD8-1]
RefSeq; XP_005254494.1; XM_005254437.4. [Q9NZD8-1]
RefSeq; XP_016877786.1; XM_017022297.1. [Q9NZD8-1]
RefSeq; XP_016877787.1; XM_017022298.1. [Q9NZD8-1]
UniGene; Hs.242458; -.
ProteinModelPortal; Q9NZD8; -.
SMR; Q9NZD8; -.
BioGrid; 119474; 44.
IntAct; Q9NZD8; 140.
MINT; Q9NZD8; -.
STRING; 9606.ENSP00000204566; -.
ESTHER; human-SPG21; Maspardin-ACP33-SPG21_like.
iPTMnet; Q9NZD8; -.
PhosphoSitePlus; Q9NZD8; -.
DMDM; 74734726; -.
EPD; Q9NZD8; -.
MaxQB; Q9NZD8; -.
PaxDb; Q9NZD8; -.
PeptideAtlas; Q9NZD8; -.
PRIDE; Q9NZD8; -.
DNASU; 51324; -.
Ensembl; ENST00000204566; ENSP00000204566; ENSG00000090487. [Q9NZD8-1]
Ensembl; ENST00000416889; ENSP00000394846; ENSG00000090487. [Q9NZD8-2]
Ensembl; ENST00000433215; ENSP00000404111; ENSG00000090487. [Q9NZD8-1]
GeneID; 51324; -.
KEGG; hsa:51324; -.
UCSC; uc002aod.5; human. [Q9NZD8-1]
CTD; 51324; -.
DisGeNET; 51324; -.
EuPathDB; HostDB:ENSG00000090487.10; -.
GeneCards; SPG21; -.
HGNC; HGNC:20373; SPG21.
HPA; HPA040407; -.
HPA; HPA040436; -.
MalaCards; SPG21; -.
MIM; 248900; phenotype.
MIM; 608181; gene.
neXtProt; NX_Q9NZD8; -.
OpenTargets; ENSG00000090487; -.
Orphanet; 101001; Autosomal recessive spastic paraplegia type 21.
PharmGKB; PA134921126; -.
eggNOG; ENOG410IETY; Eukaryota.
eggNOG; ENOG410XPCG; LUCA.
GeneTree; ENSGT00390000007857; -.
HOGENOM; HOG000236323; -.
HOVERGEN; HBG080704; -.
InParanoid; Q9NZD8; -.
KO; K19367; -.
OMA; GIDFMVD; -.
OrthoDB; EOG091G0GY0; -.
PhylomeDB; Q9NZD8; -.
TreeFam; TF105253; -.
ChiTaRS; SPG21; human.
GeneWiki; SPG21; -.
GenomeRNAi; 51324; -.
PRO; PR:Q9NZD8; -.
Proteomes; UP000005640; Chromosome 15.
Bgee; ENSG00000090487; -.
CleanEx; HS_SPG21; -.
ExpressionAtlas; Q9NZD8; baseline and differential.
Genevisible; Q9NZD8; HS.
GO; GO:0005829; C:cytosol; IDA:UniProtKB.
GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
GO; GO:0030140; C:trans-Golgi network transport vesicle; IDA:UniProtKB.
GO; GO:0042609; F:CD4 receptor binding; IPI:UniProtKB.
GO; GO:0050851; P:antigen receptor-mediated signaling pathway; IC:UniProtKB.
Gene3D; 3.40.50.1820; -; 1.
InterPro; IPR029058; AB_hydrolase.
InterPro; IPR000073; AB_hydrolase_1.
InterPro; IPR026151; Maspardin.
PANTHER; PTHR15913; PTHR15913; 1.
Pfam; PF00561; Abhydrolase_1; 1.
SUPFAM; SSF53474; SSF53474; 1.
1: Evidence at protein level;
Alternative splicing; Complete proteome; Cytoplasm; Endosome;
Golgi apparatus; Hereditary spastic paraplegia; Membrane;
Neurodegeneration; Phosphoprotein; Reference proteome.
CHAIN 1 308 Maspardin.
/FTId=PRO_0000227980.
DOMAIN 87 159 AB hydrolase-1. {ECO:0000255}.
MOD_RES 304 304 Phosphoserine.
{ECO:0000244|PubMed:20068231}.
VAR_SEQ 76 102 Missing (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_041512.
MUTAGEN 109 109 S->A: Abolishes interaction with CD4.
{ECO:0000269|PubMed:11113139}.
CONFLICT 40 40 R -> Q (in Ref. 4; BAG62906).
{ECO:0000305}.
CONFLICT 58 58 V -> A (in Ref. 4; BAG62906).
{ECO:0000305}.
CONFLICT 210 210 E -> V (in Ref. 4; BAD18813).
{ECO:0000305}.
SEQUENCE 308 AA; 34960 MW; 83C4F7B4B3EDEC7C CRC64;
MGEIKVSPDY NWFRGTVPLK KIIVDDDDSK IWSLYDAGPR SIRCPLIFLP PVSGTADVFF
RQILALTGWG YRVIALQYPV YWDHLEFCDG FRKLLDHLQL DKVHLFGASL GGFLAQKFAE
YTHKSPRVHS LILCNSFSDT SIFNQTWTAN SFWLMPAFML KKIVLGNFSS GPVDPMMADA
IDFMVDRLES LGQSELASRL TLNCQNSYVE PHKIRDIPVT IMDVFDQSAL STEAKEEMYK
LYPNARRAHL KTGGNFPYLC RSAEVNLYVQ IHLLQFHGTK YAAIDPSMVS AEELEVQKGS
LGISQEEQ
Related products :
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Pathways :
WP1654: gamma-Hexachlorocyclohexane degradation
WP1700: Selenoamino acid metabolism
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
WP1673: Naphthalene and anthracene degradation
WP1675: Nitrogen metabolism
WP1676: Non-homologous end-joining
Related Genes :
[SPG21 ACP33 BM-019 GL010] Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein) (Spastic paraplegia 21 protein)
[Spg21] Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)
[SPG21] Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)
[Spg21] Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)
[SPG21] Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)
[SPG21 QflA-14453] Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)
[spg21] Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)
[spg21] Maspardin (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog)
[ALDH16A1] Aldehyde dehydrogenase family 16 member A1
[SPG21] SPG21, maspardin
[SPG21] Maspardin
[SPG21] Maspardin isoform a (SPG21, maspardin)
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin (Spastic paraplegia 21 (Autosomal recessive, Mast syndrome))
[SPG21] SPG21, maspardin
[SPG21] Maspardin isoform a
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] Maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
[SPG21] SPG21, maspardin
Bibliography :
No related Items
Enter catalog number :
Favorites Pages:
No Favorits